Free Webinar - Oracle Argus Safety and Oracle Argus Safety Japan: A Unified Solution that Facilitates Compliant Reporting to a Japanese Regulator

https://cc.readytalk.com/r/2ojafo0abbk4

Achieving complete and efficient reporting of adverse drug reactions is a critical goal for all companies involved in developing and delivering medicinal products to the world’s population. These companies include pharmaceutical, biotech, medical device, contract research organisations (CROs), charitable and not-for-profit organisations and academic institutions.

While the challenge of efficient and effective safety reporting to two of the major regulatory agencies – FDA and EMA – is substantial, the additional challenge of reporting to the Japanese regulatory authority, the PMDA, in a way that integrates with an existing safety reporting process and function is significantly greater.
Argus Safety and Argus Safety Japan together help you to meet these challenges by providing a single global database and integrated workflow process for superior safety reporting capabilities.

This webinar will be of interest and relevance to all organisations that need a robust and proven safety system to meet their global regulatory reporting requirements. It will be of particular interest to those companies that have a requirement to report safety events to the PDMA in Japan in a timely and efficient manner that is integrated within their global safety reporting functions.

 
This webinar will provide you with:

• An overview and the business benefits of Oracle Argus Safety Suite
• The business benefits of Oracle Argus Safety Japan and integrating it with Oracle Argus Safety
• The benefits of a single global safety database and why Oracle Argus Safety Suite is the right solution for it

Tuesday, September 13, 2011 @:

7:00 a.m. US Pacific time

8:00 a.m. US Mountain time

9:00 a.m. US Central time

10:00 a.m. US Eastern time

15:00 UK time

16:00 Central European time